Axxinovar

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke Axxinovar wurde als Bildmarke am 22.08.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 26. Juli 2023

Markenform Bildmarke
Aktenzeichen 1733103
Länder Vereinigte Staaten von Amerika (USA)
Basismarke IN Nr. , 20. September 2024
Anmeldedatum 22. August 2022
Ablaufdatum 22. August 2032

Markeninhaber

1, Jagadeeswaran Street, T.Nagar,
Chennai-600017
IN

Markenvertreter

NO. C2-A, THIRU-VI-KA INDUSTRIAL ESTATE, GUINDY IN

Waren und Dienstleistungen

05 Medicinal and pharmaceutical preparations for use in the syndromic approach for treating pain, headache, fever, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory disease, obstetrical/gynecological conditions, cardiovascular disease, skin diseases, allergic reactions, musculo-skeletal and joint diseases, kidney and urological disorders, otolaryngological diseases, eye diseases, neurological system diseases, metabolic and endocrinological diseases, hematological diseases, malignant diseases, protozoal infections and conditions, sexually transmitted infections, HIV and other viral infections, nutritional disorders and poisoning; pharmaceutical preparations, namely, contraceptive preparations
35 Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others
42 Scientific and medical research and development in the fields of medicines, diagnostic aids and radio-pharmaceuticals for the treatment of pain, headaches, fevers, coughs, shock, dehydration, hypoglycemia, oral and dental conditions, gastrointestinal conditions, respiratory conditions, obstetrical/gynecological conditions and contraception, cardiovascular conditions, skin diseases and allergic reactions, musculo-skeletal and joint conditions, kidney and urological disorders, otolaryngological diseases, eye conditions, neurological conditions, metabolic and endorcinological conditions, hematological conditions, trauma and injuries, malignant disease conditions, malaria, tuberculosis, leprosy, sexually transmitted infections, HIV and other viral infections and conditions, protozoa infections and conditions, poisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
24. Juli 2023 2023/30 Gaz US Ablehnung
22. August 2022 2023/21 Gaz IN Eintragung

ID: 141733103